Ikaria Inc. Withdraws IPO, Leaving Arch, Hutch in the Lurch
Xconomy -- Ikaria, the company with the futuristic “hibernation-on-demand” technology with roots at the Fred Hutchinson Cancer Research Center in Seattle, has withdrawn its IPO plans, according to a report from Dow Jones News Services. Goldman Sachs, an underwriter of the deal, confirmed it has been withdrawn, according to the wire service.